Rigel Pharmaceuticals PE Ratio 2012-2025 | RIGL

Current and historical p/e ratio for Rigel Pharmaceuticals (RIGL) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Rigel Pharmaceuticals PE ratio as of February 11, 2026 is 5.66.
Rigel Pharmaceuticals PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2026-02-12 34.22 5.55
2025-09-30 28.33 $6.17 4.59
2025-06-30 18.73 $5.41 3.46
2025-03-31 17.99 $2.07 8.69
2024-12-31 16.82 $0.94 17.89
2024-09-30 16.18 $0.14 115.57
2024-06-30 8.22 $-0.86 0.00
2024-03-31 14.80 $-1.20 0.00
2023-12-31 14.50 $-1.50 0.00
2023-09-30 10.80 $-1.40 0.00
2023-06-30 12.90 $-2.20 0.00
2023-03-31 13.20 $-2.60 0.00
2022-12-31 15.00 $-3.40 0.00
2022-09-30 11.80 $-4.80 0.00
2022-06-30 11.30 $-4.90 0.00
2022-03-31 29.90 $-4.90 0.00
2021-12-31 26.50 $-1.10 0.00
2021-09-30 36.30 $-0.90 0.00
2021-06-30 43.40 $-0.50 0.00
2021-03-31 34.20 $-0.70 0.00
2020-12-31 35.00 $-1.60 0.00
2020-09-30 24.00 $-1.50 0.00
2020-06-30 18.30 $-1.40 0.00
2020-03-31 15.60 $-1.60 0.00
2019-12-31 21.40 $-4.00 0.00
2019-09-30 18.70 $-2.80 0.00
2019-06-30 26.10 $-3.50 0.00
2019-03-31 25.70 $-3.90 0.00
2018-12-31 23.00 $-4.50 0.00
2018-09-30 32.10 $-6.50 0.00
2018-06-30 28.30 $-6.50 0.00
2018-03-31 35.40 $-6.50 0.00
2017-12-31 38.80 $-6.10 0.00
2017-09-30 25.40 $-5.90 0.00
2017-06-30 27.30 $-6.90 0.00
2017-03-31 33.10 $-6.80 0.00
2016-12-31 23.80 $-7.40 0.00
2016-09-30 36.70 $-7.20 0.00
2016-06-30 22.30 $-5.60 0.00
2016-03-31 20.80 $-5.70 0.00
2015-12-31 30.30 $-5.90 0.00
2015-09-30 24.70 $-7.00 0.00
2015-06-30 32.10 $-8.60 0.00
2015-03-31 35.70 $-9.90 0.00
2014-12-31 22.70 $-10.30 0.00
2014-09-30 19.40 $-9.70 0.00
2014-06-30 36.30 $-10.00 0.00
2014-03-31 38.80 $-9.70 0.00
2013-12-31 28.50 $-10.10 0.00
2013-09-30 35.80 $-11.20 0.00
2013-06-30 33.40 $-12.10 0.00
2013-03-31 68.00 $-13.00 0.00
2012-12-31 65.00 $-13.30 0.00
2012-09-30 102.40 $-13.90 0.00
2012-06-30 93.00 $-12.80 0.00
2012-03-31 80.50 $-13.00 0.00
2011-12-31 78.90 $-13.80 0.00
2011-09-30 73.60 $-13.50 0.00
2011-06-30 91.70 $-1.40 0.00
2011-03-31 71.10 $7.50 9.48
2010-12-31 75.30 $7.20 10.46
2010-09-30 84.10 $5.70 14.75
2010-06-30 72.00 $-10.90 0.00
2010-03-31 79.70 $-24.20 0.00
2009-12-31 95.10 $-28.10 0.00
2009-09-30 82.00 $-32.40 0.00
2009-06-30 121.20 $-35.70 0.00
2009-03-31 61.40 $-36.90 0.00
2008-12-31 80.00 $-36.60 0.00
2008-09-30 233.50 $-33.60 0.00
2008-06-30 226.60 $-29.40 0.00
2008-03-31 186.60 $-26.90 0.00
2007-12-31 253.90 $-25.80 0.00
2007-09-30 94.30 $-25.90 0.00
2007-06-30 89.10 $-24.40 0.00
2007-03-31 108.60 $-18.50 0.00
2006-12-31 118.70 $-15.10 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.634B $0.179B
Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases. Its goal is to file one new investigative new drug application in a significant indication each year. The Company's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. We have product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia, and asthma and allergy, as well as in cancer.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $97.316B 33.99
Takeda Pharmaceutical (TAK) Japan $58.167B 11.43
Zoetis (ZTS) United States $56.704B 20.30
BeOne Medicines - (ONC) Switzerland $38.521B 204.23
Daiichi Sankyo, - (DSNKY) Japan $36.694B 18.27
Sandoz Group AG (SDZNY) Switzerland $35.913B 0.00
United Therapeutics (UTHR) United States $20.488B 18.03
Shionogi (SGIOY) Japan $19.413B 15.01
Merck (MKKGY) Germany $19.348B 11.93
Neurocrine Biosciences (NBIX) United States $13.704B 29.81
Ionis Pharmaceuticals (IONS) United States $13.663B 0.00
IPSEN (IPSEY) France $13.565B 0.00
Summit Therapeutics (SMMT) United States $11.760B 0.00
Orion OYJ (ORINY) Finland $11.502B 32.86
Madrigal Pharmaceuticals (MDGL) United States $10.924B 0.00
Eisai (ESAIY) $9.134B 0.00
Ono Pharmaceutical (OPHLF) Japan $7.656B 18.32
Crinetics Pharmaceuticals (CRNX) United States $4.864B 0.00
Stevanato Group S.p.A (STVN) Italy $4.724B 26.44
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.621B 21.94
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.591B 0.00
Corcept Therapeutics (CORT) United States $4.295B 46.40
Indivior Pharmaceuticals (INDV) United States $4.261B 17.39
NewAmsterdam Pharma (NAMS) Netherlands $3.883B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $3.167B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.941B 9.38
Hypermarcas (HYPMY) Brazil $2.835B 19.46
Dyne Therapeutics (DYN) United States $2.382B 0.00
Guardian Pharmacy Services (GRDN) United States $2.190B 42.18
Soleno Therapeutics (SLNO) United States $2.151B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.113B 0.00
Ocular Therapeutix (OCUL) United States $1.994B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.913B 22.67
Harrow (HROW) United States $1.802B 110.59
Ardelyx (ARDX) United States $1.764B 0.00
Definium Therapeutics (DFTX) United States $1.709B 0.00
Enliven Therapeutics (ELVN) United States $1.662B 0.00
Relay Therapeutics (RLAY) United States $1.586B 0.00
Amylyx Pharmaceuticals (AMLX) United States $1.576B 0.00
Oruka Therapeutics (ORKA) United States $1.559B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.441B 85.50
Collegium Pharmaceutical (COLL) United States $1.427B 7.06
Nektar Therapeutics (NKTR) United States $1.350B 0.00
Evotec AG (EVO) Germany $1.236B 0.00
Xeris Biopharma Holdings (XERS) United States $1.147B 0.00
Savara (SVRA) United States $1.089B 0.00
Cronos Group (CRON) Canada $0.992B 0.00
Theravance Biopharma (TBPH) United States $0.989B 41.51
ARS Pharmaceuticals (SPRY) United States $0.939B 0.00
Aktis Oncology (AKTS) United States $0.915B 0.00
Xencor (XNCR) United States $0.873B 0.00
Esperion Therapeutics (ESPR) United States $0.827B 0.00
KalVista Pharmaceuticals (KALV) United States $0.784B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.722B 17.08
Bioventus (BVS) United States $0.669B 13.69
ProKidney (PROK) United States $0.602B 0.00
4D Molecular Therapeutics (FDMT) United States $0.529B 0.00
Altimmune (ALT) United States $0.522B 0.00
Lyell Immunopharma (LYEL) United States $0.517B 0.00
Lexeo Therapeutics (LXEO) United States $0.496B 0.00
Zevra Therapeutics (ZVRA) United States $0.477B 0.00
Organogenesis (ORGO) United States $0.477B 0.00
Siga Technologies (SIGA) United States $0.476B 6.51
Aquestive Therapeutics (AQST) United States $0.466B 0.00
Elite Pharmaceuticals (ELTP) United States $0.464B 0.00
Nature's Sunshine Products (NATR) United States $0.457B 27.23
Akebia Therapeutics (AKBA) United States $0.411B 0.00
USANA Health Sciences (USNA) United States $0.386B 10.79
Aclaris Therapeutics (ACRS) United States $0.367B 0.00
Protara Therapeutics (TARA) United States $0.335B 0.00
Cybin (HELP) Canada $0.324B 0.00
Aldeyra Therapeutics (ALDX) United States $0.320B 0.00
Relmada Therapeutics (RLMD) United States $0.293B 0.00
Larimar Therapeutics (LRMR) United States $0.276B 0.00
Minerva Neurosciences (NERV) United States $0.274B 0.00
Enlivex Therapeutics (ENLV) Israel $0.271B 0.00
Journey Medical (DERM) United States $0.266B 0.00
Avalo Therapeutics (AVTX) United States $0.266B 0.00
OmniAb (OABI) United States $0.245B 0.00
Profound Medical (PROF) Canada $0.234B 0.00
Achieve Life Sciences (ACHV) Canada $0.228B 0.00
Context Therapeutics (CNTX) United States $0.224B 0.00
MediWound (MDWD) Israel $0.221B 0.00
Heron Therapeutics (HRTX) United States $0.215B 0.00
Surrozen (SRZN) United States $0.211B 0.00
Silence Therapeutics (SLN) United Kingdom $0.205B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.193B 0.00
Innate Pharma SA (IPHYF) France $0.181B 0.00
AleAnna (ANNA) United States $0.178B 0.00
Galectin Therapeutics (GALT) United States $0.178B 0.00
Century Therapeutics (IPSC) United States $0.156B 0.00
VAXART, INC (VXRT) United States $0.138B 0.00
Karyopharm Therapeutics (KPTI) United States $0.135B 0.00
Unicycive Therapeutics (UNCY) United States $0.134B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.134B 0.00
Prelude Therapeutics (PRLD) United States $0.131B 0.00
Inhibikase Therapeutics (IKT) United States $0.129B 0.00
Cardiol Therapeutics (CRDL) Canada $0.118B 0.00
Avita Medical (RCEL) United States $0.117B 0.00
Korro Bio (KRRO) United States $0.116B 0.00
Cassava Sciences (SAVA) United States $0.104B 0.00
Vivani Medical (VANI) United States $0.098B 0.00
Incannex Healthcare (IXHL) Australia $0.097B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.091B 0.00
Pyxis Oncology (PYXS) United States $0.084B 0.00
Champions Oncology (CSBR) United States $0.082B 34.71
Assertio Holdings (ASRT) United States $0.077B 0.00
PolyPid (PYPD) Israel $0.073B 0.00
HST Global (HSTC) United States $0.069B 0.00
Gain Therapeutics (GANX) United States $0.067B 0.00
Rafael Holdings (RFL) United States $0.062B 0.00
PMV Pharmaceuticals (PMVP) United States $0.060B 0.00
Fractyl Health (GUTS) United States $0.059B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.058B 48.38
BioNxt Solutions (BNXTF) Canada $0.057B 0.00
Dominari Holdings (DOMH) United States $0.056B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.056B 0.00
NRx Pharmaceuticals (NRXP) United States $0.054B 0.00
Nutriband (NTRB) United States $0.052B 0.00
Radnostix (INIS) United States $0.051B 0.00
Lipocine (LPCN) United States $0.048B 0.00
Acrivon Therapeutics (ACRV) United States $0.047B 0.00
ElectroCore (ECOR) United States $0.044B 0.00
Lite Strategy (LITS) United States $0.039B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Telomir Pharmaceuticals (TELO) United States $0.039B 0.00
Talphera (TLPH) United States $0.038B 0.00
Plus Therapeutics (PSTV) United States $0.038B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.030B 0.00
Wellgistics Health (WGRX) United States $0.028B 0.00
TherapeuticsMD (TXMD) United States $0.028B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.024B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Jupiter Neurosciences (JUNS) United States $0.021B 0.00
Citius Pharmaceuticals (CTXR) United States $0.019B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Scienture Holdings (SCNX) United States $0.018B 0.00
Klotho Neurosciences (KLTO) United States $0.017B 0.00
Liminatus Pharma (LIMN) United States $0.016B 0.00
Iterum Therapeutics (ITRM) Ireland $0.016B 0.00
Vivos Therapeutics (VVOS) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.016B 0.02
Cosmos Health (COSM) United States $0.015B 0.00
Vyome Holdings (HIND) United States $0.014B 0.00
Phio Pharmaceuticals (PHIO) United States $0.014B 0.00
Mannatech (MTEX) United States $0.014B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
Tempest Therapeutics (TPST) United States $0.011B 0.00
Inotiv (NOTV) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
CASI Pharmaceuticals (CASI) China $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
BioVie (BIVI) United States $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Lyra Therapeutics (LYRA) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Ernexa Therapeutics (ERNA) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
CDT Equity (CDT) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00